Literature DB >> 11439182

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

D Wang1, P S Chang, Z Wang, L Sutherland, J A Richardson, E Small, P A Krieg, E N Olson.   

Abstract

Serum response factor (SRF) regulates transcription of numerous muscle and growth factor-inducible genes. Because SRF is not muscle specific, it has been postulated to activate muscle genes by recruiting myogenic accessory factors. Using a bioinformatics-based screen for unknown cardiac-specific genes, we identified a novel and highly potent transcription factor, named myocardin, that is expressed in cardiac and smooth muscle cells. Myocardin belongs to the SAP domain family of nuclear proteins and activates cardiac muscle promoters by associating with SRF. Expression of a dominant negative mutant of myocardin in Xenopus embryos interferes with myocardial cell differentiation. Myocardin is the founding member of a class of muscle transcription factors and provides a mechanism whereby SRF can convey myogenic activity to cardiac muscle genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439182     DOI: 10.1016/s0092-8674(01)00404-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  379 in total

Review 1.  Mixed signals in heart failure: cancer rules.

Authors:  Masahiko Hoshijima; Kenneth R Chien
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Myocardial molecular biology: an introduction.

Authors:  Nigel J Brand; Paul J R Barton
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  Myocardin-related transcription factors regulate the Cdk5/Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain development.

Authors:  Mayssa H Mokalled; Aaron Johnson; Yuri Kim; Jiyeon Oh; Eric N Olson
Journal:  Development       Date:  2010-06-09       Impact factor: 6.868

4.  Functional impact of heterogeneous nuclear ribonucleoprotein A2/B1 in smooth muscle differentiation from stem cells and embryonic arteriogenesis.

Authors:  Gang Wang; Qingzhong Xiao; Zhenling Luo; Shu Ye; Qingbo Xu
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

5.  Characterization of Pax3-expressing cells from adult blood vessels.

Authors:  Olivier Goupille; Giorgia Pallafacchina; Frédéric Relaix; Simon J Conway; Ana Cumano; Benoit Robert; Didier Montarras; Margaret Buckingham
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

6.  A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.

Authors:  Christina Pagiatakis; Joseph W Gordon; Saviz Ehyai; John C McDermott
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

7.  CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation.

Authors:  Ping Xie; Yongna Fan; Hua Zhang; Yuan Zhang; Mingpeng She; Dongfeng Gu; Cam Patterson; Huihua Li
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

8.  Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.

Authors:  Kevin L Du; Hon S Ip; Jian Li; Mary Chen; Frederic Dandre; William Yu; Min Min Lu; Gary K Owens; Michael S Parmacek
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Myocardin Is Involved in Mesothelial-Mesenchymal Transition of Human Pleural Mesothelial Cells.

Authors:  Torry Tucker; Yoshikazu Tsukasaki; Tsuyoshi Sakai; Shinya Mitsuhashi; Satoshi Komatsu; Ann Jeffers; Steven Idell; Mitsuo Ikebe
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

10.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

Authors:  Hyun Kook; John J Lepore; Aaron D Gitler; Min Min Lu; Wendy Wing-Man Yung; Joel Mackay; Rong Zhou; Victor Ferrari; Peter Gruber; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.